CAP XX logo

CPX - CAP XX News Story

3.95p 1.3  49.1%

Last Trade - 07/08/20

Sector
Technology
Size
Micro Cap
Market Cap £17.4m
Enterprise Value £16.4m
Revenue £1.94m
Position in Universe 1406th / 1819

CAP-XX Limited - US court action settlement and licence agreement

Tue 2nd July, 2019 7:00am
RNS Number : 1206E
CAP-XX Limited
02 July 2019
 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

2 July 2019

 

CAP-XX Limited

("CAP-XX" or "the Company")

 

US court action settlement and licence agreement with CDE

 

CAP-XX is pleased to announce that, following a court action, it has reached agreement with Cornell-Dubilier Electronics Inc. (CDE), whereby CDE will licence two of CAP-XX's patents on a non-exclusive basis.

 

CDE is a US based privately owned capacitor manufacturer with over 35,000 customers worldwide. It is also the largest manufacturer of power capacitors in North America.

 

The royalty rate to be paid to CAP-XX is in line with the royalty rates applicable to other licence agreements with third parties. No further financial details relating to the transaction will be disclosed due to confidentiality provisions in the settlement.

 

Anthony Kongats, Chief Executive of CAP-XX said:

 

"We are delighted that CDE has settled our action.  This settlement reinforces the integrity of our intellectual property, which is critical to the production of supercapacitors as well as other related applications."

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRCKDDDBBKBKOK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.